Organicin Scientific, led by cofounder Mathew Mitchell, is spotlighted by the Extreme Tech Challenge. Focused on combating antibiotic resistance, the startup uses bacteriocins for targeted disease control. Leveraging AI, they've created a shrimp feed additive, enhancing survival rates significantly. Their go-to-market strategy involves licensing to industry leaders. Future plans include tackling agricultural diseases and human health issues.

Organicin Scientific is awarded the 2023 Manning/IALS Innovation Grant

Organicin Scientific is part of the Techstars Farm to Fork Class of 2022, a group of 12 innovative startups. This inclusion highlights their significant role in developing antibiotic alternatives for the food production sector, utilizing a bacteriocin-based drug discovery platform. Being selected for this prestigious accelerator program underscores Organicin Scientific's potential in contributing to sustainable and effective solutions in food safety and health.

The BlueSwell program's second cohort has gained remarkable momentum over its five-month duration. The teams have successfully gathered the necessary support and resources for beginning their commercial ventures. Their efforts are expected to have a significant and wide-reaching impact globally.

Three undergraduates in biology professor Peg Riley’s lab were recently selected to advance to the regional finals for the Hult Prize, the largest student start-up program in the world for early stage social start-up ventures. It recognizes “game-changing social entrepreneurs,” the organizers say.

Organicin Scientific first began after undergraduates Mathew Mitchell and Griffin O’Driscoll won early funding through the 2018-2019 Isenberg Innovation Challenge to spin out of Dr. Riley’s bacteriocin research lab.